StockData
Cytek Biosciences, Inc. logo

Cytek Biosciences, Inc. (CTKB) shareholders

CTKBNasdaqLaboratory Analytical InstrumentsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/309% below fair value
$5.70+0.07 (+1.24%)

Close on Nov 17, 2026Market cap $740.91MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
62.7%
82M of 130M shares
Institutional holders
155
29 new, 37 sold out
Net institutional buying
-3M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
BlackRock, Inc.9,356,5517.20%13G (passive) amendmentJun 30, 2026
Millennium Group Management LLC
Joint filing with Millennium Management LLC (7.20%), Israel A. Englander (7.20%) and 1 more
9,338,0107.20%13G (passive) amendmentJun 30, 2026
Boston Partners7,635,1455.91%13G (passive)Jun 30, 2026
Israel A. Englander
Joint filing with Millennium Management LLC (5.60%), Millennium Group Management LLC (5.60%)
7,281,4885.60%13G (passive) amendmentSep 30, 2026
Topline Capital Management, LLC
Joint filing with Collin McBirney (5.30%), Topline Capital Partners, LP (5.30%)
6,780,8475.30%13G (passive)Sep 25, 2025
Hillhouse Investment Management, Ltd.6,657,0305.10%13G (passive)Sep 30, 2024
Millennium Management LLC
Joint filing with Millennium Group Management LLC (5.20%), Israel A. Englander (5.20%)
6,638,8275.20%13G (passive)Apr 2, 2026

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of CTKBValueChange% of portfolio
BlackRock, Inc.9,578,6437.37%$42.43M−7,428,6260.00%
Millennium Management LLC9,338,0107.18%$41.37M+3,046,2120.01%
Boston Partners7,660,9435.89%$33.94M+1,858,1700.03%
Hhlr Advisors, Ltd.6,657,0305.12%$29.49M–3.54%
Topline Capital Management, LLC6,283,4504.83%$27.84M−781,0317.22%
Vanguard Capital Management LLC4,939,5973.80%$21.88M+176,6930.00%
Geode Capital Management, LLC3,059,5732.35%$13.56M+225,6180.00%
Dimensional Fund Advisors LP2,616,2572.01%$11.59M−47,0720.00%
State Street Corp2,566,1211.97%$11.37M−1,557,6270.00%
Goldman Sachs Group Inc2,167,5151.67%$9.60M−177,2200.00%
Royce & Associates LP2,081,5791.60%$9.22M+439,2110.07%
Russell Investments Group, Ltd.1,511,3151.16%$6.70M+151,4150.01%
Acadian Asset Management LLC1,376,0481.06%$6.09M+977,0600.01%
Bank Of America Corp /De/1,315,3321.01%$5.83M+306,2780.00%
Vanguard Portfolio Management LLC1,141,5920.88%$5.06M−1,170,2660.00%
Charles Schwab Investment Management Inc1,073,2530.83%$4.75M−31,3480.00%
Northern Trust Corp1,003,2940.77%$4.44M−1,8990.00%
Hrt Financial LP997,7690.77%$4.42M+583,7170.00%
Arrowstreet Capital, Limited Partnership973,8330.75%$4.31M+653,9240.00%
Jane Street Group, LLC906,1620.70%$4.01MNew0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 202615582M62.7%29 / 4565 / 3715M19M
Q1 202616585M65.4%24 / 6851 / 1114M4M
Q4 202515582M63.1%21 / 5261 / 1511M10M
Q3 202515380M61.8%20 / 6352 / 2411M10M
Q2 202515879M61.1%25 / 6547 / 2710M8M
Q1 202516078M59.7%30 / 5064 / 219M8M
Q4 202415277M59.4%32 / 5643 / 166M4M
Q3 202413676M58.1%20 / 6632 / 1221M5M
Q2 202412977M59.1%21 / 5541 / 166M12M
Q1 202412582M63.4%24 / 4336 / 44M1M
Q4 202310580M61.5%18 / 4429 / 196M3M
Q3 202310677M59.6%18 / 5423 / 139M8M

Top mutual fund and ETF holders

Latest monthly portfolio reports (Form N-PORT)

163 funds held CTKB in Q2 2026, 53% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.

FundShares% of CTKBValue% of fundAs of
Vanguard Total Stock Market Index Fund3,525,8482.71%$15.62M0.00%Jun 30, 2026
iShares Russell 2000 ETF3,164,6832.43%$14.02M0.02%Jun 30, 2026
Column Small Cap Select Fund2,378,9551.83%$9.97M0.53%May 31, 2026
Fidelity Small Cap Index Fund1,329,8421.02%$5.61M0.02%Jul 31, 2026
Vanguard Extended Market Index Fund1,300,3201.00%$5.76M0.01%Jun 30, 2026
iShares Russell 2000 Value ETF1,107,9500.85%$4.91M0.03%Jun 30, 2026
WPG Partners Select Small Cap Value Fund945,7190.73%$3.96M1.69%May 31, 2026
iShares Biotechnology ETF833,2570.64%$3.69M0.04%Jun 30, 2026
Goldman Sachs Small Cap Value Insights Fund639,1330.49%$2.70M0.20%Jul 31, 2026
Vanguard Russell 2000 Index Fund602,7110.46%$2.53M0.01%May 31, 2026
Royce Micro-Cap Fund572,3920.44%$2.54M0.59%Jun 30, 2026
Fidelity Extended Market Index Fund567,4670.44%$2.38M0.01%May 31, 2026
U.S. Small Cap Portfolio566,7630.44%$2.39M0.01%Jul 31, 2026
Schwab U.S. Small-Cap ETF529,9040.41%$2.22M0.01%May 31, 2026
Fidelity Enhanced Small Cap Core ETF493,8840.38%$2.19M0.04%Jun 30, 2026

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Ming YanCHIEF TECHNOLOGY OFFICER, Director4,821,8703.71%Aug 20, 2026
Wenbin JiangPRESIDENT AND CEO, Director8,248,5856.35%Aug 20, 2026
Ilan FeuchtwangChief Legal Officer, Secretary––Nov 12, 2026
William D. McCombeChief Financial Officer115,3860.09%Aug 20, 2026
Valerie BarnettCHIEF LEGAL OFFICER139,3150.11%May 20, 2026
Philippe BusqueSVP, GLOBAL SALES AND SERVICES36,7110.03%May 20, 2026
Allen PoirsonSVP BUS. AND CORP. DEV.59,9810.05%Nov 20, 2024
Richard ChinDirector28,4990.02%Aug 20, 2026
Michael HolderDirector62,8750.05%Aug 20, 2026
Glenn P. MuirDirector3,0860.00%Aug 20, 2026
Jack BallDirector86,6780.07%Jun 12, 2026
Deborah J. NeffDirector59,6790.05%Jun 12, 2026
Vera ImperDirector59,6790.05%Jun 12, 2026
Don M. HardisonDirector15,7060.01%Jun 9, 2025

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
William D. McCombe
Chief Financial Officer
Aug 18, 2026Tax withholding−2,111$4.67$9.86K115,386
William D. McCombe
Chief Financial Officer
Aug 18, 2026Option exercise+6,320––117,497
William D. McCombe
Chief Financial Officer
Aug 18, 2026Tax withholding−4,392$4.67$20.51K124,045
William D. McCombe
Chief Financial Officer
Aug 18, 2026Option exercise+16,049––140,094
William D. McCombe
Chief Financial Officer
Aug 18, 2026Tax withholding−5,401$4.67$25.22K134,693
William D. McCombe
Chief Financial Officer
Aug 18, 2026Option exercise+13,051––128,437
Glenn P. Muir
Director
Aug 18, 2026Option exercise+3,086––3,086
Ming Yan
CHIEF TECHNOLOGY OFFICER, Director
Aug 18, 2026Tax withholding−3,463$4.67$16.17K4,821,870
Ming Yan
CHIEF TECHNOLOGY OFFICER, Director
Aug 18, 2026Option exercise+14,220––4,825,333
Ming Yan
CHIEF TECHNOLOGY OFFICER, Director
Aug 18, 2026Tax withholding−1,501$4.67$7.01K4,811,113
Ming Yan
CHIEF TECHNOLOGY OFFICER, Director
Aug 18, 2026Option exercise+6,162––4,812,614
Ming Yan
CHIEF TECHNOLOGY OFFICER, Director
Aug 18, 2026Tax withholding−1,346$4.67$6.29K4,806,452
Ming Yan
CHIEF TECHNOLOGY OFFICER, Director
Aug 18, 2026Option exercise+5,525––4,807,798
Ming Yan
CHIEF TECHNOLOGY OFFICER, Director
Aug 18, 2026Tax withholding−1,778$4.67$8.30K4,802,273
Ming Yan
CHIEF TECHNOLOGY OFFICER, Director
Aug 18, 2026Option exercise+7,363––4,804,051
Michael Holder
Director
Aug 18, 2026Option exercise+2,181––62,875
Wenbin Jiang
PRESIDENT AND CEO, Director
Aug 18, 2026Option exercise+57,212––5,581,985
Wenbin Jiang
PRESIDENT AND CEO, Director
Aug 18, 2026Tax withholding−7,062$4.67$32.98K5,524,773
Wenbin Jiang
PRESIDENT AND CEO, Director
Aug 18, 2026Tax withholding−20,956$4.67$97.86K5,561,029
Wenbin Jiang
PRESIDENT AND CEO, Director
Aug 18, 2026Option exercise+29,002––5,531,835
Wenbin Jiang
PRESIDENT AND CEO, Director
Aug 18, 2026Tax withholding−5,382$4.67$25.13K5,502,833
Wenbin Jiang
PRESIDENT AND CEO, Director
Aug 18, 2026Option exercise+22,100––5,508,215
Wenbin Jiang
PRESIDENT AND CEO, Director
Aug 18, 2026Tax withholding−2,869$4.67$13.40K5,486,115
Wenbin Jiang
PRESIDENT AND CEO, Director
Aug 18, 2026Option exercise+11,781––5,488,984
Richard Chin
Director
Aug 18, 2026Option exercise+6,107––28,499
Ming Yan
CHIEF TECHNOLOGY OFFICER, Director
Jun 12, 2026Gift−135,892––4,796,688
Michael Holder
Director
Jun 10, 2026Option exercise+43,973––60,694
Deborah J. Neff
Director
Jun 10, 2026Option exercise+43,973––59,679
Vera Imper
Director
Jun 10, 2026Option exercise+43,973––59,679
Jack Ball
Director
Jun 10, 2026Option exercise+43,973––86,678
Richard Chin
Director
May 18, 2026Option exercise+6,107––22,392
Valerie Barnett
CHIEF LEGAL OFFICER
May 18, 2026Tax withholding−1,850$3.55$6.57K139,315
Valerie Barnett
CHIEF LEGAL OFFICER
May 18, 2026Option exercise+9,435––153,398
Valerie Barnett
CHIEF LEGAL OFFICER
May 18, 2026Tax withholding−2,602$3.55$9.24K143,963
Valerie Barnett
CHIEF LEGAL OFFICER
May 18, 2026Option exercise+7,250––146,565
Valerie Barnett
CHIEF LEGAL OFFICER
May 18, 2026Tax withholding−3,386$3.55$12.02K150,012
Valerie Barnett
CHIEF LEGAL OFFICER
May 18, 2026Option exercise+5,156––141,165
Valerie Barnett
CHIEF LEGAL OFFICER
May 18, 2026Tax withholding−881$3.55$3.13K136,009
Valerie Barnett
CHIEF LEGAL OFFICER
May 18, 2026Option exercise+2,454––136,890
Wenbin Jiang
PRESIDENT AND CEO, Director
May 18, 2026Tax withholding−15,009$3.55$53.28K5,477,203
Wenbin Jiang
PRESIDENT AND CEO, Director
May 18, 2026Option exercise+14,733––5,443,357
Wenbin Jiang
PRESIDENT AND CEO, Director
May 18, 2026Tax withholding−1,913$3.55$6.79K5,428,624
Wenbin Jiang
PRESIDENT AND CEO, Director
May 18, 2026Option exercise+7,854––5,430,537
Wenbin Jiang
PRESIDENT AND CEO, Director
May 18, 2026Tax withholding−3,588$3.55$12.74K5,439,769
Wenbin Jiang
PRESIDENT AND CEO, Director
May 18, 2026Option exercise+38,141––5,492,212
Wenbin Jiang
PRESIDENT AND CEO, Director
May 18, 2026Tax withholding−5,032$3.55$17.86K5,454,071
Wenbin Jiang
PRESIDENT AND CEO, Director
May 18, 2026Option exercise+19,334––5,459,103
William D. McCombe
Chief Financial Officer
May 18, 2026Tax withholding−3,122$3.55$11.08K104,317
William D. McCombe
Chief Financial Officer
May 18, 2026Option exercise+6,320––101,007
William D. McCombe
Chief Financial Officer
May 18, 2026Tax withholding−2,268$3.55$8.05K98,739
William D. McCombe
Chief Financial Officer
May 18, 2026Tax withholding−3,839$3.55$13.63K111,177
William D. McCombe
Chief Financial Officer
May 18, 2026Option exercise+10,699––115,016
William D. McCombe
Chief Financial Officer
May 18, 2026Option exercise+8,700––107,439
Philippe Busque
SVP, GLOBAL SALES AND SERVICES
May 18, 2026Option exercise+1,024––36,711
Philippe Busque
SVP, GLOBAL SALES AND SERVICES
May 18, 2026Tax withholding−1,424$3.55$5.06K43,466
Philippe Busque
SVP, GLOBAL SALES AND SERVICES
May 18, 2026Option exercise+5,551––44,890
Philippe Busque
SVP, GLOBAL SALES AND SERVICES
May 18, 2026Tax withholding−263$3.55$93436,448
Philippe Busque
SVP, GLOBAL SALES AND SERVICES
May 18, 2026Option exercise+1,473––37,921
Philippe Busque
SVP, GLOBAL SALES AND SERVICES
May 18, 2026Tax withholding−620$3.55$2.20K39,339
Philippe Busque
SVP, GLOBAL SALES AND SERVICES
May 18, 2026Option exercise+2,416––39,959

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of float
3.53%
4M shares short
Days to cover
3.6
At 1M shares a day
Change since last report
-6.9%
From 4M shares
Short volume, 20 days
36.0%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Cytek Biosciences's stock actually held short. Settlement fails (shares not delivered on time) peaked at 5,910 shares on Sep 10, 2026 over the last 90 days.

Planned insider sales

Notices of proposed sale filed on Form 144 before shares are sold

SellerFiledSharesMarket valuePlanned saleAcquired through
Philippe Busque
Officer
Sep 2, 202631,666$146.52KSep 2, 2026Stock Option Exercise
Ming Yan
Officer
Apr 9, 202440,000$268.00KApr 9, 2024Founders Shares
Ming Yan
Officer
Mar 18, 202440,000$278.00KMar 18, 2024Founders Shares
Ming Yan
Officer
Dec 19, 202320,000$184.20KDec 19, 2023Founders Shares
David Vrane
Officer
Nov 15, 202312,000$65.64KNov 15, 2023Founders Shares
Patrik Jeanmonod
Officer
Oct 24, 20239,000$41.58KOct 24, 2023Previously Exercised Stock Options
Ming Yan
Officer
Oct 19, 202340,000$193.60KOct 19, 2023Restricted Stock Units
Wenbin Jiang
Officer
Sep 7, 202360,000$413.40KSep 7, 2023Founders Shares
Ming Yan
Officer
Aug 21, 202340,000$338.40KAug 21, 2023Founders Shares
David Vrane
Officer
Aug 14, 202312,000$112.68KAug 14, 2023Founders Shares
Patrik Jeanmonod
Officer
Jul 24, 20239,000$80.10KJul 24, 2023Previously Exercised Stock Options
Ming Yan
Officer
Jun 20, 202340,000$334.00KJun 20, 2023Founders Shares
Wenbin Jiang
Officer
Jun 7, 202360,000$489.60KJun 7, 2023Founders Shares
David Vrane
Officer
May 15, 202312,000$89.88KMay 15, 2023Founders Shares
Wenbin Jiang
Director, Officer
May 8, 202320,000$238.40KMay 8, 2023Founders Shares

See a number that looks wrong?